Breast cancer resistance protein (BCRP/ABCG2)

International Journal of Biochemistry and Cell Biology

Volumn 37, Issue 4, 2005, Pages 720-725

  Staud, Frantisek ^a   Pavek, Petr ^a  

^a Charles University in Prague Faculty of Pharmacy   (Czech Republic)

Author keywords

Efflux transporter; Multidrug resistance; Pharmacokinetics; Stem cell

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN;

AMINO ACID SEQUENCE; CELLULAR DISTRIBUTION; ENZYME SPECIFICITY; EXON; GENE MUTATION; HUMAN; INTRON; NONHUMAN; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; STEM CELL; TISSUE DISTRIBUTION; TRANSCRIPTION REGULATION;

MAMMALIA;

EID: 13444288036     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2004.11.004     Document Type: Short Survey

References (20)

1. J.D. Allen, A. van Loevezijn, J.M. Lakhai, M. van der Valk, O. van Tellingen, and G. Reid Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C Molecular Cancer Therapeutics 1 2002 417 425
2. K.J. Bailey-Dell, B. Hassel, L.A. Doyle, and D.D. Ross Promoter characterization and genomic organization of the human breast cancer resistance protein (ATP-binding cassette transporter G2) gene Biochimica et Biophysica Acta 1520 2001 234 241
3. L.A. Doyle, and D.D. Ross Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2) Oncogene 22 2003 7340 7358
4. L.A. Doyle, W. Yang, L.V. Abruzzo, T. Krogmann, Y. Gao, and A.K. Rishi A multidrug resistance transporter from human MCF-7 breast cancer cells Proceedings of the National Academy of Sciences of the USA 95 1998 15665 15670
5. P.L. Ee, S. Kamalakaran, D. Tonetti, X. He, D.D. Ross, and W.T. Beck Identification of a novel estrogen response element in the breast cancer resistance protein (ABCG2) gene Cancer Research 64 2004 1247 1251
6. Y. Honjo, C.A. Hrycyna, Q.W. Yan, W.Y. Medina-Perez, R.W. Robey, and A. van de Laar Acquired mutations in the MXR/BCRP/ABCP gene alter substrate specificity in MXR/BCRP/ABCP-overexpressing cells Cancer Research 61 2001 6635 6639
7. I. Ifergan, A. Shafran, G. Jansen, J.H. Hooijberg, G.L. Scheffer, and Y.G. Assaraf Folate deprivation results in the loss of breast cancer resistance protein (BCRP/ABCG2) expression. A role for BCRP in cellular folate homeostasis Journal of Biological Chemistry 279 2004 25527 25534
8. J.W. Jonker, M. Buitelaar, E. Wagenaar, M.A. Van Der Valk, G.L. Scheffer, and R.J. Scheper The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria Proceedings of the National Academy of Sciences of the USA 99 2002 15649 15654
9. P. Krishnamurthy, D.D. Ross, T. Nakanishi, K. Bailey-Dell, S. Zhou, and K.E. Mercer The stem cell marker Bcrp/ABCG2 enhances hypoxic cell survival through interactions with heme Journal of Biological Chemistry 279 2004 24218 24225
10. C.M. Kruijtzer, J.H. Beijnen, and J.H. Schellens Improvement of oral drug treatment by temporary inhibition of drug transporters and/or cytochrome P450 in the gastrointestinal tract and liver: an overview The Oncologist 7 2002 516 530
11. S. Mizuarai, N. Aozasa, and H. Kotani Single nucleotide polymorphisms result in impaired membrane localization and reduced atpase activity in multidrug transporter ABCG2 International Journal of Cancer 109 2004 238 246
12. S.K. Rabindran, H. He, M. Singh, E. Brown, K.I. Collins, and T. Annable Reversal of a novel multidrug resistance mechanism in human colon carcinoma cells by fumitremorgin C Cancer Research 58 1998 5850 5858
13. C.W. Scharenberg, M.A. Harkey, and B. Torok-Storb The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors Blood 99 2002 507 512
14. A.H. Schinkel, and J.W. Jonker Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview Advanced Drug Delivery Reviews 55 2003 3 29
15. A. Sparreboom, H. Gelderblom, S. Marsh, R. Ahluwalia, R. Obach, and P. Principe Diflomotecan pharmacokinetics in relation to ABCG2 421C>A genotype Clinical Pharmacology and Therapeutics 76 2004 38 44
16. O. Ujhelly, C. Ozvegy, G. Varady, J. Cervenak, L. Homolya, and M. Grez Application of a human multidrug transporter (ABCG2) variant as selectable marker in gene transfer to progenitor cells Human Gene Therapy 14 2003 403 412
17. J. Xu, Y. Liu, Y. Yang, S. Bates, and J.T. Zhang Characterization of oligomeric human half-ABC transporter ATP-binding cassette G2 Journal of Biological Chemistry 279 2004 19781 19789
18. C.P. Zamber, J.K. Lamba, K. Yasuda, J. Farnum, K. Thummel, and J.D. Schuetz Natural allelic variants of breast cancer resistance protein (BCRP) and their relationship to BCRP expression in human intestine Pharmacogenetics 13 2003 19 28
19. S. Zhou, J.J. Morris, Y. Barnes, L. Lan, J.D. Schuetz, and B.P. Sorrentino Bcrp1 gene expression is required for normal numbers of side population stem cells in mice, and confers relative protection to mitoxantrone in hematopoietic cells in vivo Proceedings of the National Academy of Sciences of the USA 99 2002 12339 12344
20. S. Zhou, J.D. Schuetz, K.D. Bunting, A.M. Colapietro, J. Sampath, and J.J. Morris The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype Nature Medicine 7 2001 1028 1034